Ceolus™ and Celphere™: Asahi Kasei Microcrystalline Cellulose Products’ Post

Welcome to visit our booth in CPHI shanghai China, we will bring our capsule filling machine CFM-3500. Hope to have more discussion with you there. #CPHIShanghai #PMECShanghai #PharmaIndustry #HealthcareExhibition #PharmaceuticalSolutions #PharmaTech #PharmaInnovation #PharmaEvents #ShanghaiEvents #PharmaSupplyChain #PharmaManufacturing #PharmaceuticalMachinery #PharmaPackaging #PharmaceuticalIngredients #PharmaceuticalNetworking #PharmaceuticalExpo #PharmaBusiness #PharmaDevelopment #PharmaIndustryNews.

Dr. D.Vijaya Bharathi Bharathi, in her dynamic style, is exploring the various types of impurities and the critical role of synthesis in impurity generation. She is emphasizing how reaction conditions and methodologies impact impurity profiles during her engaging session at the 2nd Annual Pharma Impurity Conclave 2024. #EminenceBusinessMedia #EBMPIC2024 #EminenceGroupVentures

Thank you for visiting us at #CPHI2024 Milan! It was wonderful to connect with so many professionals and share our latest innovations. Missed it? No worries—here's a quick recap of our highlights! 📸✨ #CPHI2024 #PharmaInnovation #SeratecQuality #EventHighlights #Recap #SERATEC#PharmaceuticalInnovation#ourexcellenceyourtrust#OEYT#APIs#activepharmaceutical#activepharmaceuticalingredients#frenchexpertise#FDA#EMA#ANSM#drugagencies#molecules#GMP#cGMP#HAPI#API

AbbVie’s #Humira has long dominated the biosimilar market, but recent data suggests a shift is imminent with a decrease in market share to 82%. Sandoz's #Hyrimoz, a key player, has seen significant gains under the Cordavis co-label, recording a surge in prescriptions after CVS Health Caremark's move to exclude branded Humira from commercial formularies in April. IQVIA data indicates that 82% of Humira biosimilar prescriptions were for Hyrimoz by the end of April, propelling Sandoz to a 6% sales growth in the first quarter. On the other hand, AbbVie's collaboration with Cordavis has resulted in a joint Humira formulation, capturing around 25% of the Cordavis-labelled products market, as per Samsung Bioepis' findings. Meanwhile, Boehringer Ingelheim's #Cyltezo, competing with Humira, faced challenges with only 1,487 prescriptions since its July 2023 launch, compared to Humira's 2.8 million prescriptions during the same period. The delayed uptake led to layoffs within Boehringer's customer-facing team, prompting a shift to a hybrid approach. As AbbVie prepares to transition focus to newer immunology medications like #Skyrizi and #Rinvoq to counter Humira's declining sales – dropping from a record $21.2 billion to $14.4 billion last year – the pharma landscape is evolving rapidly. Skyrizi's recent $2 billion quarterly sales almost matched Humira, which experienced a 40% sales decline in the first quarter. The pharmaceutical market is witnessing dynamic shifts and strategic maneuvers as key players navigate the evolving landscape. ------------- Stay tuned for more insights on PharmaTell Studio or read more on our blog: https://lnkd.in/gTtPWGMk

We are heading to #CPHIMilan this October! Come say hello at #Booth24A1, #Hall24, #ZoneIntegratedPharma, to experience the unmatched strengths of Hetero's global marketing arms. Discover the unified power of Hetero — Camber Pharmaceuticals Inc, Amarox Pharma GmbH, SEVEN PHARMA - LATAM, and HETERO HEALTHCARE LIMITED — as we come together under our transformative theme: #ForEveryoneEverywhere Driven by a singular purpose: to #inspire human #belief in a #healthierworld, we cater to your #API, #FDF, #CDMO, and #Biosimilars needs. Let's #collaborate, #innovate, and serve #EveryoneEverywhere Together, we create #HealthForAll. 📅 Date: 8-10 October 2024 📍 Location: CPHI Milan, #FieraMilano-Italy; Booth: 24A1, Hall 24, Zone Integrated Pharma #Hetero #CPHI2024 #Pharma #GlobalHealth #AffordableMedicines #ForEveryoneEverywhere #CPHI

Starting the day with a focus on the most challenging topic, nitrosamine and mutagenic impurities, Dr. Ramesh Jagadeesan is addressing the root causes of NDSRIs and showcasing advanced tools to predict impurities and identify potential risks in real-time at the 2nd Annual Pharma Impurity Conclave 2024. #EminenceBusinessMedia #EBMPIC2024 #EminenceGroupVentures

The countdown has begun!!! In just over two weeks, CPhI Worldwide will open its doors in Milan, and we will be there as always! We are excited to announce Navin Molecular's participation at the show. As a leading CDMO, we’re eager to showcase our cutting-edge solutions and discuss how we can help bring your innovations into the clinic. If you want to learn more about the technologies and capabilities we have in small molecules, which cover the entire product life cycle from development through to cGMP commercial manufacturing, please stop by our stand (7F14) where you can meet with the commercial team and our CEO, Rajendra Kumar Sahu, and discover how we can accelerate your project from concept to commercial production! Let's partner to drive innovation in the industry and grow together! Jordi Robinson, Ajay K. Ohri, Irfan Khan, Jay Ezhuthachan, Sagar Gawade, Jorg Gitzel, Matthew Stent #CPHI2024 #CPHIMilan #CDMO #Businessdevelopment #growth #ChemicalManufacturing #Innovation #Sustainability #IndustrialExcellence #Pharma #Chemical #Contractmanufacturing #opportunity #CRAMS #manufacturing #Customsynthesis #processdevelopment #Clinicalphasemanufacturing #supportforfilling #development #NCE #intermediates #processvalidation #regulatoryfilling #analyticaldevelopment #flowchemistry #peptides #processengineering #processsafety #intellectualproperty #Inlicensing #drugdiscovery #flourinechemistry #Phase I #Phase II #Phase III #Launched

Ready for 3rd day!!! QPLAB Pharma Services is at CPHI connecting with partners and customers (and a bit of networking!!!) #analyticalservices #nitrosamines #batchrelease #batchtesting #analyticalmethods #analyticaldevelopment

Yesterday I shared that one of the #biosimilar manufacturers was getting out of the Humira game. It has been well reported that biosimilar uptake has been slow. In fact, in February of this year, a year after the first biosimilar came out, #Humira still held on to 96% of the market share 😕 Why? It is a multifactor answer as the challenges are many, but we will unpack these at our Innovative Rx Strategies webinar today at noon ET (link in comments). Something that has to be part of the challenge conversation is the role that #PBMs have played, timely in light of yesterday's #FTC report. One PBM made one decision and Humira's market share dropped to 81% in under 2 months. 😲 #Pharmacists #Pharmacybenefits #webinar

Attending CPHI China is a strategic imperative for pharmaceutical companies involved in API supply and manufacturing. This premier event offers unparalleled networking opportunities, allowing companies to connect with key industry players, potential clients, and strategic partners from around the globe. Additionally, CPHI China showcases the latest advancements in pharmaceutical technology and API manufacturing, providing valuable insights into industry trends and innovations. By participating in this event, companies can stay updated on market developments, discover new products, and integrate cutting-edge solutions into their operations, enhancing efficiency and competitiveness. Moreover, CPHI China serves as a platform to strengthen supplier relationships and boost brand visibility. Face-to-face interactions with existing and potential suppliers facilitate better deals and ensure supply chain reliability. Exhibiting at the event also allows companies to showcase their products and innovations to a global audience, attracting new customers and investors. To maximize these benefits, our specialized travel packages offer convenient travel arrangements, comfortable accommodations, and assistance with event registration, ensuring a seamless and productive experience. Investing in a travel package with us enables pharmaceutical professionals to focus on making the most of CPHI China, driving business growth and securing a competitive edge in the industry. #PharmaIndustry #PharmaInnovation #PharmaLeadership #DrugDiscovery #HealthcareSolutions #PharmaTech #Biopharma #MedicalResearch #PharmaManufacturing #PharmaLife #HealthcareAdvancements #PharmaMarketing #ClinicalTrials #PharmaNews #BioTech #CPHIChina #PharmaNetworking #CPHIBusiness #PharmaInnovation #CPHIExpo #ChinaPharmaMarket #CPHIConnections #PharmaIndustry #CPHIShanghai #PharmaCollaboration #CPHI2024 #PharmaLeaders #CPHIEssentials #PharmaEvents #CPHITradeShow Ajaz Raien Khan Imran